Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Adrien Tempescul"'
Autor:
S. de Guibert, S François, Adrien Tempescul, Stéphane Leprêtre, V. Levy, Véronique Morel, Sylvain Choquet, Marie-Sarah Dilhuydy, Pauline Brice, Luc Mathieu Fornecker, Loic Ysebaert, Jehan Dupuis
Publikováno v:
Clinical Lymphoma, Myeloma & Leukemia
Clinical Lymphoma, Myeloma & Leukemia, 2015, 15 (2), pp.e43-6. ⟨10.1016/j.clml.2014.07.013⟩
Clinical Lymphoma, Myeloma & Leukemia, Elsevier, 2015, 15 (2), pp.e43-6. ⟨10.1016/j.clml.2014.07.013⟩
Clinical Lymphoma, Myeloma & Leukemia, 2015, 15 (2), pp.e43-6. ⟨10.1016/j.clml.2014.07.013⟩
Clinical Lymphoma, Myeloma & Leukemia, Elsevier, 2015, 15 (2), pp.e43-6. ⟨10.1016/j.clml.2014.07.013⟩
International audience; Background - The Autorisation Temporaire d'Utilisation (ATU) is an early access program available in France for drugs aimed at treating severe diseases not yet covered by a marketing authorization, for patients without any oth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a9f244c6c4576feaac2e6d144660071
https://doi.org/10.1016/j.clml.2014.07.013
https://doi.org/10.1016/j.clml.2014.07.013
Autor:
Alix Baugier de Materre, Delphine Bolle, Adrien Tempescul, Anne Besançon, Stéphanie Poulain, Catherine Truong, Kamel Laribi, Jonathan Farhi, Pierre Lemaire, Jean Christophe Ianotto, Andreea Anghel, Habib Ghnaya, Nathalie Denizon
Publikováno v:
Hematological Oncology
Hematological Oncology, Wiley, 2016, ⟨10.1002/hon.2334⟩
Hematological Oncology, Wiley, 2016, ⟨10.1002/hon.2334⟩
International audience; Primary nodal marginal zone lymphoma (NMZL) is a rare disease. There is no current consensus on how to treat it. The bendamustine plus rituximab (BR) regimen is effective for the treatment of follicular and other indolent lymp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b281dea19514150856445ebe22054ea
Autor:
Kamel, Laribi, Adrien, Tempescul, Habib, Ghnaya, Nathalie, Denizon, Anne, Besançon, Andreea, Anghel, Jonathan, Farhi, Catherine, Truong, Pierre, Lemaire, Stephanie, Poulain, Delphine, Bolle, Jean Christophe, Ianotto, Alix, Baugier de Materre
Publikováno v:
Hematological oncology. 35(4)
Primary nodal marginal zone lymphoma (NMZL) is a rare disease. There is no current consensus on how to treat it. The bendamustine plus rituximab (BR) regimen is effective for the treatment of follicular and other indolent lymphomas, but its efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3468ac09cc6ae0c09f72ede63737e1b0
https://pubmed.ncbi.nlm.nih.gov/27443419
https://pubmed.ncbi.nlm.nih.gov/27443419
Autor:
Jehan Dupuis, Selim Corm, Remy Gressin, Roch Houot, Christiane Mounier, Sylvain Carras, Caroline Dartigeas, M. Macro, Ghandi Damaj, Nicolas Daguindau, Mary Callanan, Jean-Michel Pignon, Anne-Sophie Moreau, S. Le Gouill, Adrien Tempescul, P. Feugier, Fabrice Jardin, Guillaume Cartron, Luc Mathieu Fornecker, I. Ysebaert, A. Bannos, Lionel Karlin, J. Fleury, Anna Schmitt, Cecile Chabrot
Publikováno v:
Hematological Oncology. 35:141-142
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77327bb6f3baf34834288a922d6f1161
https://doi.org/10.1002/hon.2437_131
https://doi.org/10.1002/hon.2437_131
Autor:
Krimo Bouabdallah, Guillaume Cartron, Christiane Mounier, Jehan Dupuis, Selim Corm, Caroline Dartigeas, Nicolas Daguindau, Roch Houot, Steven Le Gouill, J. Fleury, Fabrice Jardin, Luc Fornecker, Anne Schmitt, Adrien Tempescul, Loic Ysebaert, Barbara Burroni, Anne Moreau, Remy Gressin, Jean-Michel Pignon, Sylvain Carras, Lionel Karlin
Publikováno v:
Blood. 128:5302-5302
Background The proliferation index (PI), defined by KI67 protein expression has been identified as a key prognostic factor (PF) in mantle cell lymphoma (MCL) (1, 2). A GOELAMS/LYSA study (n = 113 patients) identified a cut point of 26% for KI67 posit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e0fb8e2f0465eef480ed08d8e6a2c0a
https://doi.org/10.1182/blood.v128.22.5302.5302
https://doi.org/10.1182/blood.v128.22.5302.5302
Autor:
Noel Milpied, Julien Rossignol, Gandhi Damaj, Sarah Guenounou, Eric Durot, Norbert Ifrah, Caroline Algrin, Antoine Bonnet, Jérôme Cornillon, Veronique Leblond, Emmanuel Gyan, Sylvain Choquet, Inès Boussen, Adrien Chauchet, Adrien Tempescul, Jeremy Delage, Arnaud Jaccard, Fontanet Bijou
Publikováno v:
Blood. 128:4230-4230
Introduction Post-transplant lymphoproliferative disorders (PTLD) are a rare but severe complication occurring after organ transplantation as a result of immunosuppressive therapy (IST). Until recently, there was no consensus regarding best treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57527c90f6e4938407b86ab55d8829b5
https://doi.org/10.1182/blood.v128.22.4230.4230
https://doi.org/10.1182/blood.v128.22.4230.4230